A phase III study of topical alprostadil cream (Femprox) for female sexual arousal disorder.
Phase of Trial: Phase III
Latest Information Update: 04 May 2012
At a glance
- Drugs Alprostadil (Primary)
- Indications Female sexual dysfunction
- Focus Proof of concept; Registrational; Therapeutic Use
- 01 Aug 2008 Primary endpoint 'Sexual-satisfaction' has been met.
- 01 Aug 2008 Results have been published in The Journal of Sexual Medicine.
- 20 Nov 2007 New trial record.